Program 2017
| Thursday | October 5 |
|---|---|
| Coffe and sandwich will be served from 08.30 | |
| 09.00-10.00 | Registration |
| 10.00 | Satellite symposium – AbbVie Keep CALM and treat to target Jean-Frederic Colombel, Jonas Halfvarson |
| 10.45 | Opening of the meeting Tom Øresland |
| 10.50 | Session 1 Moderators: Einar Bjørnsson, Hans Strid |
| 10.50 | Defect colonic mucus as primary ulcerative colitis cause – are there any therapeutic possibilities? Gunnar Hansson |
| 11.10 | The role of the mesentery in Crohn’s disease Christianne Buskens |
| 11.30 | Multidimensional markers of risk in families of IBD patients Charlotte Hedin |
| 11.50 | Lunch |
| 12.45 | Session 2 Moderators: Ebbe Langholz, Tom Øresland |
| 12.45 | The preclinical phase of IBD – road to prevention? Jean-Frederic Colombel |
| 13.10 | Appendectomy for sustained remission in UC Christianne Buskens |
| 13.30 | Surgery in Crohns disease after the introduction of biological treatment Bjørn Moum |
| 13.50 | Non resectional surgery for Crohn's disease Anthony de Buck van Overstraeten |
| 14.10 | Prevention of post-operative recurrence in Crohn Edouard Louis |
| 14.30 | Coffee break |
| 15.00 | Session 3 Moderators: Einar Bjørnsson, Michael Eberhardson |
| 15.00 | Treatment de-escalation in Crohn Edouard Louis |
| 15.20-15.40 | Inflammatory bowel disease and intestinal cancer Tine Jess |
| 15.45-16.30 | Satellite symposium – Takeda When to swap or switch? – are all biologics the same in the long run? Chair: Jonas Halfvarson, Sweden. Speakers: Edouard Louis, Belgium, Bjørn Moum, Norway. |
| 16.35-17.20 | Satellite symposium – Janssen Treating the patients of tomorrow Speakers: Michael Eberhardson, Jörgen Jahnsen |
| 17.25 | Adjourn & mingle |
| 20.00 | Dinner at Hotel Hilton Slussen Stockholm |
| Friday | October 6 |
|---|---|
| Coffe and sandwich will be served from 07.30 | |
| 08.15 | Satellite symposium – MSD New Insights and Technologies to improve Management and Outcomes in UC Patient Chair: Michael Eberhardson Speakers: Gert Van Assche, Belgium, Walter Reinisch, Austria |
| 09.00 | Presentation of five selected abstracts Tom Øresland |
| 09.30 | Session 4 Moderators: Susanna Jäghult, Hans Strid |
| 09.30 | The transanal/single port IPAA technique Anthony de Buck van Overstraeten |
| 09.50 | Anti-IL-12/23 therapies in IBD Arthur Kaser |
| 10.10 | Coffee break |
| 10.50 | Session 5 Moderators: Ebbe Langholz, Einar Bjørnsson |
| 10.50 | How deep is deep? Endoscopic, transmural and histological healing Gert van Assche |
| 11.10 | Risks associated with anti-TNF in patients with IBD Tine Jess |
| 11.30 | Tandem talk A gastroenterolist meets an immunologist: Monitoring biological therapy Taina Sipponen and Sakari Jokiranta |
| 12.10 | Lunch |
| 13.10 | Session 6 Moderators: Hans Strid, Susanna Jäghult |
| 13.10 | Fatigue in IBD Palle Bager |
| 13.30 | Affordable health care? Costs and benefits of our treatments Gert van Assche |
| 13.50 | Environment – gene interaction conspiring in the mucosa to trigger IBD Arthur Kaser |
| 14.10 | Do immune-modulators alter long term surgical outcomes in IBD Richard Pollok |
| 14.30 | Coffee break |
| 15.00 | Session 7 Moderators: Jonas Halfvarson, Ebbe Langholz |
| 15.00 | Microscopic colitis – what is new? Andreas Munch |
| 15.20 | Steroids, use and misuse in IBD Richard Pollok |
| 15.50 | Best poster award Tom Øresland |
| 16.00 | Adjourn |